scispace - formally typeset
C

Cherry Yin-Yi Chang

Researcher at China Medical University (Taiwan)

Publications -  40
Citations -  559

Cherry Yin-Yi Chang is an academic researcher from China Medical University (Taiwan). The author has contributed to research in topics: Endometriosis & Retrospective cohort study. The author has an hindex of 12, co-authored 34 publications receiving 394 citations. Previous affiliations of Cherry Yin-Yi Chang include University of Michigan.

Papers
More filters
Journal ArticleDOI

Use of autologous buccal mucosa for vaginoplasty: a study of eight cases

Wu Chou Lin, +3 more
- 01 Mar 2003 - 
TL;DR: This is the first reported procedure of vaginoplasty with autologous buccal mucosa as graft material and provides good cosmetic results, and improves the vaginal length of the patient.
Journal ArticleDOI

Association of Pelvic Inflammatory Disease with Risk of Endometriosis: A Nationwide Cohort Study Involving 141,460 Individuals

Fei-Wu Tai, +4 more
- 24 Oct 2018 - 
TL;DR: It is demonstrated that patients with PID had a three-fold increase in the risk of developing endometriosis (HR = 3.02, 95% CI = 2.85–3.2).
Journal ArticleDOI

Increased risk of endometriosis in patients with lower genital tract infection: A nationwide cohort study

Wu Chou Lin, +5 more
- 01 Mar 2016 - 
TL;DR: Cox proportional hazards models showed that irrespective of comorbidities, lower genital tract infection was an independent risk factor for endometriosis, and patients withLower genital tract infections exhibit a substantially higher risk for developing endometRIosis.
Journal ArticleDOI

MUC4 gene polymorphisms associate with endometriosis development and endometriosis-related infertility

Cherry Yin-Yi Chang, +10 more
- 24 Feb 2011 - 
TL;DR: Protein sequence analysis indicated that amino acid substitutions by genetic variations at rs882605, rs2688513 and rs2246901 occur in the putative functional loops and the type D von Willebrand factor (VWFD) domain in the MUC4 sequence.
Journal ArticleDOI

RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.

Xiangyu Wang, +14 more
TL;DR: RSF-1 participates in the tumor progression of cervical cancer and could be considered as an early prognostic marker for cancer development and clinical outcome and Therapies based on anti-RSf-1 activity may be beneficial for patients with RSF- 1 overexpression in their tumors.